There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.

ChemSpider 2D Image | Fruquintinib | C21H19N3O5


  • Molecular FormulaC21H19N3O5
  • Average mass393.393 Da
  • Monoisotopic mass393.132477 Da
  • ChemSpider ID39625837

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1194506-26-7 [RN]
3-Benzofurancarboxamide, 6-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N,2-dimethyl- [ACD/Index Name]
6-[(6,7-Dimethoxy-4-chinazolinyl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamid [German] [ACD/IUPAC Name]
6-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide [ACD/IUPAC Name]
6-[(6,7-Diméthoxy-4-quinazolinyl)oxy]-N,2-diméthyl-1-benzofurane-3-carboxamide [French] [ACD/IUPAC Name]
fruquintinib [Spanish] [INN]
fruquintinib [French] [INN]
Fruquintinib [INN]
fruquintinibum [Latin] [INN]

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Target Organs:

      VEGFR inhibitor TargetMol T2656
    • Bio Activity:

      Fruquintinib (HMPL-013) inhibits VEGFR family member (VEGFR1, 2, 3) with IC50s of 33 nM, 35 nM and 0.5 nM, respectively with weak inhibition of RET, FGFR-1 and c-kit kinases. ;IC50 value: 33/35/ 0.5 nM (VEGFR1/2/3);Target: VEGFR;In vitro: Fruquintinib (HMPL-013) is a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy. Fruquintinib inhibits VEGFR2 (KDR) with an IC50 of 25 nM in the Z-lyte assay. Fruquintinib suppresses VEGF/VEGFR signaling and cell proliferation in HUVECs and HLECs. Fruquintinib inhibits tubule sprouting and prevents angiogenesis. [1];In vivo: Fruquintinib potently inhibits VEGF induced KDR phosphorylation in lung tissue of mouse. Fruquintinib inhibits tumor growth in multiple human xenograft models. [1] MedChem Express HY-19912
      Protein Tyrosine Kinase/RTK; MedChem Express HY-19912
      Tyrosine Kinase/Adaptors TargetMol T2656
      VEGFR MedChem Express HY-19912
      VEGFR TargetMol T2656

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.3±0.1 g/cm3
Boiling Point: 600.5±55.0 °C at 760 mmHg
Vapour Pressure: 0.0±1.7 mmHg at 25°C
Enthalpy of Vaporization: 89.4±3.0 kJ/mol
Flash Point: 317.0±31.5 °C
Index of Refraction: 1.639
Molar Refractivity: 108.7±0.3 cm3
#H bond acceptors: 8
#H bond donors: 1
#Freely Rotating Bonds: 5
#Rule of 5 Violations: 0
ACD/LogP: 3.08
ACD/LogD (pH 5.5): 2.51
ACD/BCF (pH 5.5): 47.80
ACD/KOC (pH 5.5): 554.16
ACD/LogD (pH 7.4): 2.51
ACD/BCF (pH 7.4): 47.83
ACD/KOC (pH 7.4): 554.56
Polar Surface Area: 96 Å2
Polarizability: 43.1±0.5 10-24cm3
Surface Tension: 52.3±3.0 dyne/cm
Molar Volume: 302.1±3.0 cm3

Click to predict properties on the Chemicalize site